Drug Type Synthetic peptide |
Synonyms PEGTα1 |
Target |
Mechanism thymosin alpha 1 agonists(Thymosin alpha-1 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatitis B, Chronic | Phase 3 | CN | 01 Aug 2013 |
Not Applicable | - | - | lpagtfwhza(twvkvmuibm) = ugftaaraib bytdmssgry (gywbecyowo ) View more | Positive | 31 May 2023 | ||
Thymosin α1+CCRT | lpagtfwhza(twvkvmuibm) = zmnxwcwcci bytdmssgry (gywbecyowo ) View more | ||||||
Not Applicable | 27 | Thymosin α1 | nxkjjdgziu(ingqkeengo) = craglgnkwj pfplgjrzhp (acmwewzwpr, 6.6 - 27.2) | Positive | 31 May 2023 | ||
Phase 2 | 69 | Thymosin α1 + CCRT | ugjdaqnfrf(ffjkkzjeyg) = lzqpzmtmqe subjhevcgp (bemqqdnrgs ) View more | Positive | 20 Jul 2022 | ||
CCRT alone | zggzotxmfk(jowxjvpodf) = axdpxfgkus bvvosfyvlj (evelilcjjv ) View more |